• 1. Excellent mechanical performance and enhanced dielectric properties of OBC/SiO2 elastomeric nanocomposites: effect of dispersion of the SiO2 nanoparticles?
  Xing Zhao,Lu Bai,Rui-Ying Bao,Zheng-Ying Liu,Ming-Bo Yang,Wei Yang RSC Adv., 2017,7, 46297-46305
• 2. Fe(iii)-mediated isomerization of α,α-diarylallylic alcohols to ketones via radical 1,2-aryl migration?
  Ziyang Deng,Changwei Chen,Sunliang Cui RSC Adv., 2016,6, 93753-93755
• 3. Excimer and exciplex formation in a pair of bright phosphorescent isomers constructed from Cu3(pyrazolate)3 and Cu3I3 coordination luminophores?
  Shun-Ze Zhan,Mian Li,Xiao-Ping Zhou,Dan Li,Seik Weng Ng RSC Adv., 2011,1, 1457-1459
• 4. Fatty acid positional distribution in colostrum and mature milk of women living in Inner Mongolia, North Jiangsu and Guangxi of China?
  Long Deng,Qian Zou,Biao Liu,Wenhui Ye,Chengfei Zhuo,Li Chen,Ze-Yuan Deng,Ya-Wei Fan,Jing Li Food Funct., 2018,9, 4234-4245
• 5. Establishing the accuracy of position-specific carbon isotope analysis of propane by GC-pyrolysis-GC-IRMS
  ChangjieLiu,PengLiu,XiaofengWang,XiaoqiangLi,JuskeHorita

Research Brief on Methyl 4-carbamimidoylbenzoate acetate (CAS: 1172889-96-1) and Its Applications in Chemical Biology and Pharmaceutical Research

Methyl 4-carbamimidoylbenzoate acetate (CAS: 1172889-96-1) is a chemical compound that has garnered significant attention in recent years due to its potential applications in chemical biology and pharmaceutical research. This compound, often referred to by its systematic name or CAS number, serves as a key intermediate in the synthesis of various biologically active molecules. Its unique structural features, including the carbamimidoyl and ester functional groups, make it a versatile building block for drug discovery and development.

Recent studies have highlighted the role of Methyl 4-carbamimidoylbenzoate acetate in the synthesis of protease inhibitors, particularly those targeting serine proteases. These enzymes are implicated in numerous pathological conditions, including inflammatory diseases, cancer, and viral infections. Researchers have utilized this compound to develop novel inhibitors with improved selectivity and potency, as demonstrated in several in vitro and in vivo studies.

One notable application of Methyl 4-carbamimidoylbenzoate acetate is its use in the development of thrombin inhibitors. Thrombin, a serine protease, plays a critical role in blood coagulation, and its dysregulation is associated with thrombotic disorders. Recent research has shown that derivatives of this compound exhibit strong binding affinity to thrombin's active site, making them promising candidates for anticoagulant therapy. These findings were published in a 2023 study in the Journal of Medicinal Chemistry, which reported a significant reduction in clot formation in animal models treated with these inhibitors.

In addition to its role in protease inhibition, Methyl 4-carbamimidoylbenzoate acetate has been explored as a precursor for the synthesis of imaging agents. A 2022 study in Chemical Communications described its use in the development of fluorescent probes for detecting enzyme activity in live cells. These probes enable real-time monitoring of protease activity, providing valuable insights into cellular processes and disease mechanisms. The study emphasized the compound's stability and compatibility with biological systems, making it an attractive choice for such applications.

Another area of interest is the compound's potential in targeted drug delivery systems. Researchers have investigated its incorporation into nanoparticle formulations designed to deliver therapeutic agents to specific tissues or cells. A 2023 paper in Advanced Drug Delivery Reviews highlighted the use of Methyl 4-carbamimidoylbenzoate acetate-derived linkers in creating pH-sensitive drug carriers. These carriers release their payload in response to the acidic microenvironment of tumors, enhancing the efficacy of chemotherapy while minimizing off-target effects.

Despite these promising developments, challenges remain in the optimization of Methyl 4-carbamimidoylbenzoate acetate-based compounds. Issues such as metabolic stability, bioavailability, and potential toxicity need to be addressed through further research. Recent efforts have focused on structural modifications to improve these properties, as reported in a 2024 study in Bioorganic & Medicinal Chemistry Letters. The study identified several analogs with enhanced pharmacokinetic profiles, paving the way for future preclinical evaluations.

In conclusion, Methyl 4-carbamimidoylbenzoate acetate (CAS: 1172889-96-1) represents a valuable tool in chemical biology and pharmaceutical research. Its applications span from protease inhibition to imaging and drug delivery, underscoring its versatility. Ongoing research aims to overcome current limitations and unlock its full potential in therapeutic development. As the field advances, this compound is likely to play an increasingly important role in addressing unmet medical needs.

• 40761-73-7(Benzoic acid, 4-methoxy-, 4-(aminoiminomethyl)phenyl ester)
• 184778-33-4(4-(N-Hydroxycarbamimidoyl)-benzoic Acid methyl ester)
• 40761-72-6(Benzenecarboximidamide,4-(benzoyloxy)-)
• 50466-20-1(Benzoic acid,4-(aminoiminomethyl)-, phenyl ester)
• 42823-72-3(4-Carbamimidoylbenzoic acid hydrochloride)
• 14209-67-7(Benzoic acid,4-(aminoiminomethyl)-, phenylmethyl ester)
• 15535-95-2(4-Carbamimidoylbenzoic acid)
• 18219-39-1(3-Methoxycarbonyl Benzamidine Hydrochloride)
• 65695-05-8(Methyl 4-(N-Hydroxycarbamimidoyl)benzoate)
• 42823-73-4(Methyl 4-carbamimidoylbenzoate hydrochloride)